Anticoccidial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Drug Class (Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes), By Drug Action (Coccidiostatic, Coccidiocidal), By Animal Type (Production Animals, Companion Animals), By Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels) By Reg

Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Anticoccidial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Drug Class (Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes), By Drug Action (Coccidiostatic, Coccidiocidal), By Animal Type (Production Animals, Companion Animals), By Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels) By Reg

Forecast Period 2025-2029
Market Size (2023) USD 1.34 Billion
CAGR (2024-2029) 3.86%
Fastest Growing Segment Companion Animals
Largest Market North America
Market Size (2029) USD 1.65 Billion

MIR Animal Healthcare

 Ask for Discount  Request Customization 

Market Overview

Global Anticoccidial Drugs Market was valued at USD 1.34 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 3.86% through 2029. The global anticoccidial drugs market is a dynamic and rapidly evolving sector within the animal health industry, driven by the escalating demand for livestock products worldwide and the persistent threat of coccidiosis in poultry, cattle, swine, and other animals. Coccidiosis, caused by protozoan parasites of the genus Eimeria, poses significant economic losses to the livestock industry due to reduced productivity, morbidity, and mortality rates. As a result, the market for anticoccidial drugs has witnessed substantial growth, propelled by the increasing adoption of intensive farming practices, rising concerns over food safety and animal welfare, and the emergence of drug-resistant strains of coccidia. Key players in the market continue to invest in research and development activities to introduce novel formulations with improved efficacy, safety profiles, and compatibility with various production systems.

Advancements in biotechnology and molecular biology have facilitated the development of alternative strategies such as vaccines, probiotics, and enzymes for coccidiosis control, thereby intensifying competition within the market. Geographically, North America and Europe dominate the global anticoccidial drugs market owing to the high concentration of livestock farms, stringent regulations governing animal health, and substantial investments in research and development. However, Asia-Pacific is anticipated to witness significant growth in the coming years, driven by the expansion of the livestock sector, increasing disposable incomes, and growing awareness regarding the benefits of preventive healthcare measures in animal production. Moreover, the ongoing COVID-19 pandemic has underscored the importance of biosecurity and disease prevention in livestock farming, thereby accentuating the demand for anticoccidial drugs and other veterinary pharmaceuticals.

The regulatory constraints, concerns over antimicrobial resistance, and the shift towards organic and sustainable farming practices pose challenges to market growth. The global anticoccidial drugs market is poised for continued expansion, fueled by technological advancements, evolving consumer preferences, and the persistent need to enhance animal health and productivity in an increasingly competitive agricultural landscape.

Key Market Drivers

Escalating Demand for Livestock Products

The escalating demand for livestock products is a significant factor driving the growth of the global anticoccidial drugs market. As the world's population continues to grow, so does the demand for animal-derived products such as meat, dairy, and eggs. This increasing demand has led to the expansion of intensive farming practices, where large numbers of animals are raised in confined spaces to meet the growing need for protein-rich food sources.

The intensification of livestock production also brings with it challenges, including a higher risk of disease outbreaks such as coccidiosis. Coccidiosis is a parasitic disease caused by protozoan parasites of the genus Eimeria, which infect the intestinal tract of poultry, cattle, swine, and other animals, leading to reduced productivity and economic losses for farmers.

To meet the rising demand for livestock products while mitigating the risks posed by diseases like coccidiosis, farmers increasingly rely on anticoccidial drugs to protect the health and productivity of their animals. These drugs work by controlling the growth and spread of coccidia in the intestines, thereby reducing the severity of the disease and its impact on livestock performance.

The growing awareness among farmers about the importance of disease prevention and biosecurity measures has further fueled the demand for anticoccidial drugs. Farmers recognize the need to safeguard their animals against diseases that can compromise their health and productivity, and anticoccidial drugs offer an effective means of achieving this goal.

The intensification of livestock production has led to a greater emphasis on maximizing efficiency and profitability. Anticoccidial drugs play a crucial role in achieving these objectives by helping to maintain optimal growth rates, feed conversion ratios, and overall performance in livestock. By controlling coccidiosis and reducing the incidence of disease-related losses, these drugs enable farmers to achieve higher yields and better returns on their investment.

The escalating demand for livestock products is driving increased utilization of anticoccidial drugs in the global market. As the need for protein-rich food sources continues to grow, the demand for effective disease control measures such as anticoccidial drugs is expected to remain strong, driving further growth and innovation in the global anticoccidial drugs market.

Rising Prevalence of Coccidiosis

The rising prevalence of coccidiosis is a significant driver behind the growth of the global anticoccidial drugs market. Coccidiosis is a parasitic disease caused by various species of the protozoan parasite Eimeria, affecting a wide range of livestock species including poultry, cattle, swine, and sheep. This disease poses a substantial threat to the livestock industry, leading to reduced productivity, increased morbidity and mortality rates, and significant economic losses for farmers.

Several factors contribute to the increasing prevalence of coccidiosis globally. Firstly, the intensification of livestock production practices, characterized by higher stocking densities and increased contact between animals, creates favorable conditions for the transmission and spread of coccidia. Additionally, factors such as poor sanitation, inadequate biosecurity measures, and the reuse of contaminated bedding or litter can further exacerbate the prevalence of the disease.

Climate change and environmental factors also play a role in the rising prevalence of coccidiosis. Changes in temperature and humidity can create optimal conditions for the survival and proliferation of coccidia oocysts in the environment, increasing the risk of infection for susceptible animals. Globalization and the movement of livestock and poultry across regions and borders have facilitated the spread of coccidia to previously unaffected areas, contributing to the expansion of the disease's geographical range.

The increasing prevalence of drug-resistant strains of coccidia is another factor driving the demand for anticoccidial drugs. Over time, repeated exposure to anticoccidial drugs can lead to the development of resistance in coccidia populations, rendering traditional treatment options less effective. As a result, there is a growing need for new and innovative anticoccidial drugs with novel modes of action to combat drug-resistant strains and provide effective control of the disease.

MIR Segment1

 Ask for Discount  Request Customization 

Technological Advancements in Drug Development

Technological advancements in drug development have significantly contributed to the growth and innovation within the global anticoccidial drugs market. These advancements encompass a wide range of scientific and technological breakthroughs, including novel drug formulations, improved delivery systems, and enhanced understanding of the biology and pathogenesis of coccidiosis. One of the key areas of advancement in anticoccidial drug development is the introduction of novel formulations with improved efficacy and safety profiles. Pharmaceutical companies are investing in research and development to identify new drug candidates and optimize existing compounds to enhance their effectiveness against coccidia. This includes the development of next-generation anticoccidial drugs that target specific stages of the parasite life cycle or exploit vulnerabilities in coccidia metabolism, leading to more targeted and efficient treatment options.

Furthermore, advancements in drug delivery systems have revolutionized the way anticoccidial drugs are administered to animals. Traditional methods of drug administration, such as oral medications or medicated feed, are being complemented by innovative delivery technologies such as injectable formulations, slow-release implants, and medicated water systems. These delivery systems offer greater convenience, precision, and control over drug dosing, ensuring optimal efficacy while minimizing the risk of under- or overdosing.

Biotechnology and genetic engineering have also played a significant role in advancing the field of anticoccidial drug development. Researchers are leveraging techniques such as recombinant DNA technology and gene editing to produce recombinant proteins, antibodies, and vaccines targeting coccidia parasites. These biotechnological approaches offer novel strategies for disease control and prevention, including the development of genetically modified organisms with enhanced resistance to coccidiosis or the production of recombinant vaccines capable of inducing protective immunity against multiple strains of coccidia.

Advancements in high-throughput screening, bioinformatics, and computational modeling have accelerated the process of drug discovery and development, enabling researchers to identify potential drug candidates more rapidly and cost-effectively. This has led to an increase in the number of new anticoccidial drugs entering the market and expanded the range of treatment options found at to farmers and veterinarians.

Key Market Challenges

Regulatory Constraints

One of the significant challenges hindering the global anticoccidial drugs market is regulatory constraints imposed by governmental bodies and regulatory agencies. These regulations often vary across different regions and countries, creating complexities for manufacturers seeking to gain approval for their products. Stringent requirements for safety, efficacy, and quality assurance necessitate extensive preclinical and clinical testing, which can be time-consuming and costly. Additionally, concerns over antimicrobial resistance have prompted regulatory agencies to impose restrictions on the use of certain classes of antimicrobials, including anticoccidial drugs, further limiting the availability and usage of these products in some markets. Navigating the regulatory landscape requires significant resources and expertise, posing a barrier to entry for smaller pharmaceutical companies and hindering innovation within the market.

Concerns Over Antimicrobial Resistance

Another key challenge facing the global anticoccidial drugs market is the growing concern over antimicrobial resistance. Prolonged and widespread use of antimicrobial agents, including anticoccidial drugs, can contribute to the development of resistant strains of coccidia parasites, rendering traditional treatment options less effective. This not only undermines the efficacy of existing drugs but also poses a threat to animal health and welfare. Furthermore, antimicrobial resistance has broader implications for public health, as resistant pathogens can be transmitted from animals to humans through the food chain or environmental contamination. As a result, there is increasing pressure from consumers, policymakers, and regulatory agencies to promote the responsible use of antimicrobials in livestock production and to develop alternative strategies for disease control that minimize the risk of resistance development.

MIR Regional

 Ask for Discount  Request Customization 

Emerging Alternatives to Anticoccidial Drugs

The emergence of alternative strategies for coccidiosis control presents a challenge to the global anticoccidial drugs market. Advances in biotechnology, immunology, and microbiology have led to the development of alternative approaches such as vaccines, probiotics, prebiotics, and plant-derived compounds for preventing and managing coccidiosis in livestock. These alternatives offer potential advantages such as reduced risk of antimicrobial resistance, improved animal welfare, and enhanced consumer acceptance. As a result, there is growing interest and investment in these alternative solutions, leading to increased competition for market share within the anticoccidial drugs market.

Key Market Trends

Expansion Of Intensive Farming Practices Worldwide

With the global population steadily increasing and dietary preferences shifting towards protein-rich diets, there is a growing demand for livestock products such as meat, dairy, and eggs. To meet this demand, farmers are increasingly adopting intensive farming methods, characterized by high stocking densities and confined housing systems.

Intensive farming practices also create ideal conditions for the transmission and spread of diseases like coccidiosis. Coccidia parasites thrive in warm, humid environments, making densely populated livestock facilities particularly susceptible to outbreaks. Coccidiosis can cause significant economic losses for farmers due to decreased productivity, increased mortality rates, and the cost of treatment and prevention measures.

As a result, there is a rising demand for effective disease control measures, including anticoccidial drugs, to safeguard animal health and productivity in intensive farming operations. Anticoccidial drugs play a crucial role in preventing and managing coccidiosis by controlling the growth and spread of coccidia parasites in infected animals. By minimizing the incidence and severity of the disease, these drugs help farmers maintain optimal growth rates, feed conversion ratios, and overall productivity in their livestock herds.

The intensification of livestock production has led to increased awareness among farmers about the importance of disease prevention and management. Farmers recognize the significant impact that diseases like coccidiosis can have on their bottom line and are therefore willing to invest in preventive measures to protect their animals and ensure profitability. Anticoccidial drugs are a key component of these disease management strategies, providing farmers with a reliable and cost-effective solution for controlling coccidiosis in their herds.

Focus on Animal Health and Welfare

The global anticoccidial drugs market is witnessing a notable boost due to an increasing focus on animal health and welfare. As consumer awareness grows regarding the conditions in which livestock are raised and the impact of farming practices on animal well-being, there is a corresponding demand for products and practices that promote healthier, happier animals. This focus on animal welfare has led to significant changes within the agricultural industry, including a heightened emphasis on disease prevention and management.

Coccidiosis, caused by protozoan parasites of the genus Eimeria, poses a significant threat to animal health and productivity, particularly in intensive farming operations. Infected animals can suffer from reduced growth rates, decreased feed efficiency, and increased mortality rates, leading to economic losses for farmers. In response, there has been a growing recognition of the importance of implementing effective disease control measures, such as the use of anticoccidial drugs, to safeguard animal health and welfare.

Anticoccidial drugs play a crucial role in preventing and controlling coccidiosis in livestock populations. By controlling the growth and spread of coccidia parasites, these drugs help to minimize the incidence and severity of the disease, thereby improving animal well-being and productivity. Farmers and livestock producers recognize the importance of maintaining healthy animals not only for ethical reasons but also for economic sustainability.

The focus on animal health and welfare extends beyond individual farm practices to encompass broader societal concerns about antibiotic resistance and food safety. There is increasing pressure from consumers, policymakers, and regulatory agencies to reduce the use of antibiotics in livestock production and to adopt alternative disease management strategies that prioritize animal welfare and environmental sustainability. In this context, anticoccidial drugs offer a valuable solution for controlling coccidiosis while minimizing the use of antibiotics in animal agriculture. These drugs are an essential tool for farmers seeking to maintain high standards of animal health and welfare while meeting the growing demand for sustainably produced meat, dairy, and eggs.

Segmental Insights

Drug Class Insights

Based on the

Drug Action Insights

Based on drug action, Coccidiostatic emerged as the dominant segment in the global anticoccidial drugs market in 2023. This is due to their ability to suppress parasite growth without eliminating them entirely, potentially reducing the likelihood of resistance development. Coccidiostatic drugs may offer a more sustainable approach, allowing for prolonged use while maintaining efficacy. This could appeal to farmers seeking long-term solutions for managing coccidiosis in their livestock, thus driving demand for coccidiostatic drugs in the market.

Regional Insights

North America emerged as the dominant player in the global anticoccidial drugs market in 2023, holding the largest market share.

Recent Developments

  • In June 2023, Amlan International, the animal nutrition and health division of Oil-Dri Corporation of America, a global pioneer in mineral science with over 80 years of experience, announced the successful acquisition of the remaining non-controlling interest of Agromex Importaciones, S.A. de C.V. on May 12, 2023. Amlan now possesses full ownership of its subsidiary in Mexico, further strengthening its presence in the Mexican market. This ownership consolidation underscores Amlan's dedication to delivering the highest standards of operational excellence as a dependable partner in animal production, providing proven products and exceptional technical support. With this acquisition, Agromex will benefit from the guidance of a new Board of Directors comprising industry experts and seasoned professionals.

Key Market Players

  • Vetoquinol SA
  • Zoetis Philippines Inc 
  • Phibro Animal HealthCorporation
  • Huvepharma, Inc
  • Elanco US Inc. 
  • Biochem Pharmaceutical Industries Ltd 
  • Ceva Sante Animale SA 
  • Impextraco NV
  • Boehringer IngelheimInternational GmbH
  • Merck & Co., Inc.

By Drug Class

By Drug Action

By Animal Type

By Distribution Channel

By Region
  • Ionophore
  • Antibiotic
  • Sulphonamides
  • Chemical Derivative
  • Other Drug Classes
  • Coccidiostatic
  • Coccidiocidal
  • Production Animals
  • Companion Animals
  • Veterinary Hospitals
  • Retail Pharmacy
  • Other Distribution Channels
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Table of Content

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased Database
                        1.3.2. GVR’s Internal Database
                        1.3.3. Secondary Sources
                        1.3.4. Primary Research
                    1.4. Information/Data Analysis
                    1.5. Market Formulation & Visualization
                    1.6. Data Validation & Publishing
                    1.7. Model Details
                        1.7.1. Commodity flow analysis
                        1.7.2. Global Market: CAGR Calculation
                    1.8. List of Secondary Sources
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Veterinary Medicine Market Variable Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market
                        3.1.2. Ancillary Market
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Rise In Livestock Population And Increasing Pet Ownership Rates
                            3.2.1.2. Increase In The Number Of Zoonotic & Chronic Diseases
                            3.2.1.3. Rising R&D And Procedural Advancements
                            3.2.1.4. Increasing Consumption Of Meat And Mandatory Vaccinations
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Government Intervention
                            3.2.2.2. Increasing Influx Of Counterfeit Drugs
                            3.2.2.3. Short Product Exclusivity PeriodRising research on antibiotic alternatives
                        3.2.3. Market Opportunity Analysis
                        3.2.4. Market Challenge Analysis
                    3.3. Veterinary Medicine Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Bargaining power of suppliers
                            3.3.1.2. Bargaining power of buyers
                            3.3.1.3. Threat of substitution
                            3.3.1.4. Threat of new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political & Legal Landscape
                            3.3.2.2. Economic and Social Landscape
                            3.3.2.3. Technological landscape
                            3.3.2.4. Environmental Landscape
                    3.4. Regulatory Framework
                    3.5. Estimated Animal Population by key species & key countries, 2018-2024
                    3.6. User Perspective Analysis
                        3.6.1. Pet owners
                        3.6.2. Veterinarians
                        3.6.3. Pharmaceutical companies
                        3.6.4. Regulatory bodies
                        3.6.5. Retailers and distributors
                        3.6.6. Agricultural sector
                    3.7. COVID-19 Impact Analysis
Chapter 4. Veterinary Medicine Market: Product Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Veterinary Medicine Market: Product Movement Analysis
                    4.3. Veterinary Medicine Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
                    4.4. Biologics
                        4.4.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.4.2. Vaccine
                            4.4.2.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.2.2. Modified/ Attenuated Live
                                4.4.2.2.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.2.3. Inactivated (Killed)
                                4.4.2.3.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.4.2.4. Other Vaccines
                                4.4.2.4.1. Other Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.4.3. Other Biologics
                            4.4.3.1. Other Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Pharmaceuticals
                        4.5.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.5.1.1. Parasiticides
                                4.5.1.1.1. Parasiticides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.5.1.2. Anti-infectives
                                4.5.1.2.1. Anti-infectives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.5.1.3. Anti-inflammatory
                                4.5.1.3.1. Anti-inflammatory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.5.1.4. Analgesics
                                4.5.1.4.1. Analgesics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.5.1.5. Others
                                4.5.1.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Medicated Feed Additives
                        4.6.1. Medicated Feed Additives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Veterinary Medicine Market: By Animal Type Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Veterinary Medicine Market: By Animal Type Movement Analysis
                    5.3. Veterinary Medicine Market Size & Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
                        5.3.1. Production Animals
                            5.3.1.1. Production Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.1.2. Poultry
                                5.3.1.2.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.1.3. Pigs
                                5.3.1.3.1. Pigs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.1.4. Cattles
                                5.3.1.4.1. Cattles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.1.5. Sheep & Goats
                                5.3.1.5.1. Sheep & Goats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.1.6. Others
                                5.3.1.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.2. Companion Animals
                            5.3.2.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.2. Dogs
                                5.3.2.2.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.3. Cats
                                5.3.2.3.1. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.4. Horses
                                5.3.2.4.1. Horses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.5. Others
                                5.3.2.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Veterinary Medicine Market: By Route of Administration Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Veterinary Medicine Market: By Route of Administration Movement Analysis
                    6.3. Veterinary Medicine Market Size & Trend Analysis, by Route Of Administration, 2018 to 2030 (USD Million)
                        6.3.1. Oral
                            6.3.1.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.3.2. Injectables
                            6.3.2.1. Injectables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.3.3. Topical
                            6.3.3.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.3.4. Other routes
                            6.3.4.1. Other routes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Veterinary Medicine Market: By Distribution Channel Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. Veterinary Medicine Market: By Distribution Channel Movement Analysis
                    7.3. Veterinary Medicine Market Size & Trend Analysis by Distribution Channel, 2018 to 2030 (USD Million)
                        7.3.1. Veterinary Hospitals & clinics
                            7.3.1.1. Veterinary Hospitals & clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.2. E-commerce
                            7.3.2.1. E-commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.3. Offline retail stores
                            7.3.3.1. Offline retail stores Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        7.3.4. Others
                            7.3.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Veterinary Medicine Market: Regional Estimates & Trend Analysis
                    8.1. Regional Dashboard
                    8.2. Veterinary Medicine Market Share, By Region, 2024 & 2030, USD Million
                    8.3. Regional Outlook
                    8.4. North America
                        8.4.1. North America Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.4.2. U.S.
                            8.4.2.1. Key Country Dynamics
                            8.4.2.2. U.S. Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.4.3. Canada
                            8.4.3.1. Key Country Dynamics
                            8.4.3.2. Canada Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.4.4. Mexico
                            8.4.4.1. Key Country Dynamics
                            8.4.4.2. Mexico Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                    8.5. Europe
                        8.5.1. Europe Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.5.2. UK
                            8.5.2.1. Key Country Dynamics
                            8.5.2.2. UK Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.5.3. Germany
                            8.5.3.1. Key Country Dynamics
                            8.5.3.2. Germany Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.5.4. France
                            8.5.4.1. Key Country Dynamics
                            8.5.4.2. France Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.5.5. Italy
                            8.5.5.1. Key Country Dynamics
                            8.5.5.2. Italy Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.5.6. Spain
                            8.5.6.1. Key Country Dynamics
                            8.5.6.2. Spain Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.5.7. Denmark
                            8.5.7.1. Key Country Dynamics
                            8.5.7.2. Denmark Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.5.8. Sweden
                            8.5.8.1. Key Country Dynamics
                            8.5.8.2. Sweden Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.5.9. Norway
                            8.5.9.1. Key Country Dynamics
                            8.5.9.2. Norway Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.5.10. Netherlands
                            8.5.10.1. Key Country Dynamics
                            8.5.10.2. Romania Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                    8.6. Asia Pacific
                        8.6.1. Asia Pacific Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.6.2. Japan
                            8.6.2.1. Key Country Dynamics
                            8.6.2.2. Japan Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.6.3. China
                            8.6.3.1. Key Country Dynamics
                            8.6.3.2. China Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.6.4. India
                            8.6.4.1. Key Country Dynamics
                            8.6.4.2. India Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.6.5. Australia
                            8.6.5.1. Key Country Dynamics
                            8.6.5.2. Australia Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.6.6. South Korea
                            8.6.6.1. Key Country Dynamics
                            8.6.6.2. South Korea Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.6.7. Thailand
                            8.6.7.1. Key Country Dynamics
                            8.6.7.2. Thailand Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                    8.7. Latin America
                        8.7.1. Latin America Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.7.2. Brazil
                            8.7.2.1. Key Country Dynamics
                            8.7.2.2. Brazil Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.7.3. Argentina
                            8.7.3.1. Key Country Dynamics
                            8.7.3.2. Argentina Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                    8.8. Middle East & Africa
                        8.8.1. Middle East & Africa Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.8.2. South Africa
                            8.8.2.1. Key Country Dynamics
                            8.8.2.2. South Africa Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.8.3. Saudi Arabia
                            8.8.3.1. Key Country Dynamics
                            8.8.3.2. Saudi Arabia Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.8.4. UAE
                            8.8.4.1. Key Country Dynamics
                            8.8.4.2. UAE Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.8.5. Kuwait
                            8.8.5.1. Key Country Dynamics
                            8.8.5.2. Kuwait Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.8.6. Egypt
                            8.8.6.1. Key Country Dynamics
                            8.8.6.2. Egypt Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        8.8.7. Israel
                            8.8.7.1. Key Country Dynamics
                            8.8.7.2. Israel Veterinary Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Market Participant Categorization
                    9.2. Company Market Position Analysis/ Heap Map Analysis
                    9.3. Company Profiles
                        9.3.1. Zoetis Inc.
                            9.3.1.1. Participant’s Overview
                            9.3.1.2. Financial Performance
                            9.3.1.3. Product Benchmarking
                            9.3.1.4. Strategic Initiatives
                        9.3.2. Boehringer Ingelheim International Gmbh
                            9.3.2.1. Participant’s Overview
                            9.3.2.2. Financial Performance
                            9.3.2.3. Product Benchmarking
                            9.3.2.4. Strategic Initiatives
                        9.3.3. Merck & Co., Inc.
                            9.3.3.1. Participant’s Overview
                            9.3.3.2. Financial Performance
                            9.3.3.3. Product Benchmarking
                            9.3.3.4. Strategic Initiatives
                        9.3.4. Elanco
                            9.3.4.1. Participant’s Overview
                            9.3.4.2. Financial Performance
                            9.3.4.3. Product Benchmarking
                            9.3.4.4. Strategic Initiatives
                        9.3.5. Ceva
                            9.3.5.1. Participant’s Overview
                            9.3.5.2. Financial Performance
                            9.3.5.3. Product Benchmarking
                            9.3.5.4. Strategic Initiatives
                        9.3.6. Dechra Pharmaceuticals PLC
                            9.3.6.1. Participant’s Overview
                            9.3.6.2. Financial Performance
                            9.3.6.3. Product Benchmarking
                            9.3.6.4. Strategic Initiatives
                        9.3.7. Phibro Animal Health Corporation
                            9.3.7.1. Participant’s Overview
                            9.3.7.2. Financial Performance
                            9.3.7.3. Product Benchmarking
                            9.3.7.4. Strategic Initiatives
                        9.3.8. Virbac S.A.
                            9.3.8.1. Participant’s Overview
                            9.3.8.2. Financial Performance
                            9.3.8.3. Product Benchmarking
                            9.3.8.4. Strategic Initiatives
                        9.3.9. Bimeda, Corporate
                            9.3.9.1. Participant’s Overview
                            9.3.9.2. Financial Performance
                            9.3.9.3. Product Benchmarking
                            9.3.9.4. Strategic Initiatives
                        9.3.10. Biogenesis Bago
                            9.3.10.1. Participant’s Overview
                            9.3.10.2. Financial Performance
                            9.3.10.3. Product Benchmarking
                            9.3.10.4. Strategic Initiatives
                    9.4. Strategy Mapping
                        9.4.1. Mergers & Acquisitions
                        9.4.2. Partnerships & Collaborations
                        9.4.3. Expansion
                        9.4.4. Product launch
                        9.4.5. Product Approval
                        9.4.6. Others
                    9.5. List of Other Players

 

List of Tables

Table 1 List of secondary sources
Table 2 Global Veterinary Medicine market, by region, 2018 - 2030 (USD Million)
Table 3 Global Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 4 Global Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 5 Global Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 6 Global Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 7 Global Biologics market, by Type, 2018 - 2030 (USD Million)
Table 8 Global Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 9 Global Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 10 Global Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 11 Global Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 12 North America Veterinary Medicine market, by country, 2018 - 2030 (USD Million)
Table 13 North America Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 14 North America Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 15 North America Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 16 North America Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 17 North America Biologics market, by Type, 2018 - 2030 (USD Million)
Table 18 North America Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 19 North America Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 20 North America Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 21 North America Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 22 U.S. Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 23 U.S. Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 24 U.S. Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 25 U.S. Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 26 U.S. Biologics market, by Type, 2018 - 2030 (USD Million)
Table 27 U.S. Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 28 U.S. Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 29 U.S. Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 30 U.S. Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 31 Canada Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 32 Canada Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 33 Canada Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 34 Canada Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 35 Canada Biologics market, by Type, 2018 - 2030 (USD Million)
Table 36 Canada Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 37 Canada Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 38 Canada Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 39 Canada Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 40 Europe Veterinary Medicine market, by country, 2018 - 2030 (USD Million)
Table 41 Europe Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 42 Europe Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 43 Europe Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 44 Europe Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 45 Europe Biologics market, by Type, 2018 - 2030 (USD Million)
Table 46 Europe Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 47 Europe Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 48 Europe Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 49 Europe Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 50 UK Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 51 UK Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 52 UK Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 53 UK Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 54 UK Biologics market, by Type, 2018 - 2030 (USD Million)
Table 55 UK Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 56 UK Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 57 UK Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 58 UK Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 59 Germany Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 60 Germany Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 61 Germany Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 62 Germany Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 63 Germany Biologics market, by Type, 2018 - 2030 (USD Million)
Table 64 Germany Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 65 Germany Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 66 Germany Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 67 Germany Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 68 France Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 69 France Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 70 France Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 71 France Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 72 France Biologics market, by Type, 2018 - 2030 (USD Million)
Table 73 France Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 74 France Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 75 France Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 76 France Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 77 Italy Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 78 Italy Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 79 Italy Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 80 Italy Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 81 Italy Biologics market, by Type, 2018 - 2030 (USD Million)
Table 82 Italy Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 83 Italy Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 84 Italy Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 85 Italy Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 86 Spain Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 87 Spain Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 88 Spain Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 89 Spain Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 90 Spain Biologics market, by Type, 2018 - 2030 (USD Million)
Table 91 Spain Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 92 Spain Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 93 Spain Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 94 Spain Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 95 Netherlands Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 96 Netherlands Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 97 Netherlands Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 98 Netherlands Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 99 Netherlands Biologics market, by Type, 2018 - 2030 (USD Million)
Table 100 Netherlands Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 101 Netherlands Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 102 Netherlands Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 103 Netherlands Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 104 Norway Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 105 Norway Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 106 Norway Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 107 Norway Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 108 Norway Biologics market, by Type, 2018 - 2030 (USD Million)
Table 109 Norway Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 110 Norway Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 111 Norway Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 112 Norway Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 113 Denmark Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 114 Denmark Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 115 Denmark Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 116 Denmark Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 117 Denmark Biologics market, by Type, 2018 - 2030 (USD Million)
Table 118 Denmark Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 119 Denmark Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 120 Denmark Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 121 Denmark Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 122 Sweden Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 123 Sweden Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 124 Sweden Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 125 Sweden Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 126 Sweden Biologics Market, by Type, 2018 - 2030 (USD Million)
Table 127 Sweden Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 128 Sweden Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 129 Sweden Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 130 Sweden Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 131 Asia Pacific Veterinary Medicine market, by country, 2018 - 2030 (USD Million)
Table 132 Asia Pacific Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 133 Asia Pacific Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 134 Asia Pacific Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 135 Asia Pacific Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 136 Asia Pacific Biologics market, by Type, 2018 - 2030 (USD Million)
Table 137 Asia Pacific Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 138 Asia Pacific Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 139 Asia Pacific Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 140 Asia Pacific Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 141 Japan Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 142 Japan Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 143 Japan Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 144 Japan Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 145 Japan Biologics market, by Type, 2018 - 2030 (USD Million)
Table 146 Japan Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 147 Japan Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 148 Japan Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 149 Japan Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 150 China Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 151 China Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 152 China Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 153 China Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 154 China Biologics market, by Type, 2018 - 2030 (USD Million)
Table 155 China Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 156 China Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 157 China Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 158 China Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 159 India Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 160 India Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 161 India Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 162 India Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 163 India Biologics market, by Type, 2018 - 2030 (USD Million)
Table 164 India Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 165 India Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 166 India Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 167 India Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 168 South Korea Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 169 South Korea Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 170 South Korea Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 171 South Korea Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 172 South Korea Biologics market, by Type, 2018 - 2030 (USD Million)
Table 173 South Korea Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 174 South Korea Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 175 South Korea Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 176 South Korea Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 177 Australia Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 178 Australia Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 179 Australia Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 180 Australia Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 181 Australia Biologics market, by Type, 2018 - 2030 (USD Million)
Table 182 Australia Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 183 Australia Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 184 Australia Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 185 Australia Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 186 Thailand Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 187 Thailand Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 188 Thailand Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 189 Thailand Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 190 Thailand Biologics market, by Type, 2018 - 2030 (USD Million)
Table 191 Thailand Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 192 Thailand Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 193 Thailand Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 194 Thailand Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 195 Latin America Veterinary Medicine market, by country, 2018 - 2030 (USD Million)
Table 196 Latin America Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 197 Latin America Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 198 Latin America Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 199 Latin America Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 200 Latin America Biologics market, by Type, 2018 - 2030 (USD Million)
Table 201 Latin America Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 202 Latin America Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 203 Latin America Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 204 Latin America Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 205 Brazil Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 206 Brazil Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 207 Brazil Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 208 Brazil Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 209 Brazil Biologics market, by Type, 2018 - 2030 (USD Million)
Table 210 Brazil Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 211 Brazil Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 212 Brazil Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 213 Brazil Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 214 Mexico Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 215 Mexico Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 216 Mexico Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 217 Mexico Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 218 Mexico Biologics market, by Type, 2018 - 2030 (USD Million)
Table 219 Mexico Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 220 Mexico Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 221 Mexico Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 222 Mexico Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 223 Argentina Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 224 Argentina Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 225 Argentina Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 226 Argentina Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 227 Argentina Biologics market, by Type, 2018 - 2030 (USD Million)
Table 228 Argentina Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 229 Argentina Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 230 Argentina Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 231 Argentina Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 232 MEA Veterinary Medicine market, by country, 2018 - 2030 (USD Million)
Table 233 MEA Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 234 MEA Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 235 MEA Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 236 MEA Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 237 MEA Biologics market, by Type, 2018 - 2030 (USD Million)
Table 238 MEA Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 239 MEA Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 240 MEA Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 241 MEA Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 242 South Africa Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 243 South Africa Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 244 South Africa Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 245 South Africa Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 246 South Africa Biologics market, by Type, 2018 - 2030 (USD Million)
Table 247 South Africa Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 248 South Africa Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 249 South Africa Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 250 South Africa Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 251 Saudi Arabia Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 252 Saudi Arabia Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 253 Saudi Arabia Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 254 Saudi Arabia Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 255 Saudi Arabia Biologics market, by Type, 2018 - 2030 (USD Million)
Table 256 Saudi Arabia Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 257 Saudi Arabia Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 258 Saudi Arabia Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 259 Saudi Arabia Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 260 UAE Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 261 UAE Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 262 UAE Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 263 UAE Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 264 UAE Biologics market, by Type, 2018 - 2030 (USD Million)
Table 265 UAE Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 266 UAE Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 267 UAE Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 268 UAE Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 269 Kuwait Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 270 Kuwait Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 271 Kuwait Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 272 Kuwait Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 273 Kuwait Biologics market, by Type, 2018 - 2030 (USD Million)
Table 274 Kuwait Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 275 Kuwait Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 276 Kuwait Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 277 Kuwait Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 278 Egypt Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 279 Egypt Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 280 Egypt Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 281 Egypt Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 282 Egypt Biologics market, by Type, 2018 - 2030 (USD Million)
Table 283 Egypt Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 284 Egypt Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 285 Egypt Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 286 Egypt Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 287 Israel Veterinary Medicine market, by Animal Type, 2018 - 2030 (USD Million)
Table 288 Israel Veterinary Medicine market, by Product, 2018 - 2030 (USD Million)
Table 289 Israel Veterinary Medicine market, by Route of Administration, 2018 - 2030 (USD Million)
Table 290 Israel Veterinary Medicine market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 291 Israel Biologics market, by Type, 2018 - 2030 (USD Million)
Table 292 Israel Vaccines market, by Type, 2018 - 2030 (USD Million)
Table 293 Israel Pharmaceuticals market, by Type, 2018 - 2030 (USD Million)
Table 294 Israel Production Animals market, by Type, 2018 - 2030 (USD Million)
Table 295 Israel Companion Animals market, by Type, 2018 - 2030 (USD Million)
Table 296 Participant’s overview
Table 297 Financial performance
Table 298 Product benchmarking
Table 299 Strategic Initiatives
Table 300 List of Other Key Market Players

 

List Of Figures

Fig. 1 Veterinary Medicine market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Data Analysis Models
Fig. 6 Market Formulation And Validation
Fig. 7 Data Validating & Publishing
Fig. 8 General methodology for commodity flow analysis of animal health market
Fig. 9 Commodity flow analysis
Fig. 10 Parent market analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Parent Market Analysis, 2023 (USD Billion)
Fig. 16 Ancillary market outlook, 2023
Fig. 17 Veterinary Medicine Market Dynamics
Fig. 18 Average annual U.S. pet owner spending in USD (2022)
Fig. 19 Veterinary medicine market: PORTER’s analysis
Fig. 20 Veterinary medicine market PESTEL analysis
Fig. 21 Veterinary Medicine market by animal type: Key takeaways
Fig. 22 Veterinary Medicine market by animal type, Market share, 2023 & 2030
Fig. 23 Production animals market, 2018 - 2030 (USD Million)
Fig. 24 Poultry market, 2018 - 2030 (USD Million)
Fig. 25 Pigs market, 2018 - 2030 (USD Million)
Fig. 26 Cattle market, 2018 - 2030 (USD Million)
Fig. 27 Sheep & Goats market, 2018 - 2030 (USD Million)
Fig. 28 Others market, 2018 - 2030 (USD Million)
Fig. 29 Companion animals market, 2018 - 2030 (USD Million)
Fig. 30 Dogs market, 2018 - 2030 (USD Million)
Fig. 31 Cats market, 2018 - 2030 (USD Million)
Fig. 32 Horses market, 2018 - 2030 (USD Million)
Fig. 33 Others market, 2018 - 2030 (USD Million)
Fig. 34 Veterinary Medicine market by Product: Key takeaways
Fig. 35 Veterinary Medicine market by Distribution Channel, market share, 2023 & 2030
Fig. 36 Biologics market, 2018 - 2030 (USD Million)
Fig. 37 Vaccine market, 2018 - 2030 (USD Million)
Fig. 38 Modified/attenuated live market, 2018 - 2030 (USD Million)
Fig. 39 Inactivated (killed) market, 2018 - 2030 (USD Million)
Fig. 40 Other vaccines market, 2018 - 2030 (USD Million)
Fig. 41 Others market, 2018 - 2030 (USD Million)
Fig. 42 Pharmaceuticals market, 2018 - 2030 (USD Million)
Fig. 43 Parasiticides market, 2018 - 2030 (USD Million)
Fig. 44 Anti-infectives market, 2018 - 2030 (USD Million)
Fig. 45 Anti-inflammatory market, 2018 - 2030 (USD Million)
Fig. 46 Analgesics market, 2018 - 2030 (USD Million)
Fig. 47 Others market, 2018 - 2030 (USD Million)
Fig. 48 Medicated feed additives market, 2018 - 2030 (USD Million)
Fig. 49 Veterinary Medicine market by route of administration: Key takeaways
Fig. 50 Veterinary Medicine market by route of administration, market share, 2023 & 2030
Fig. 51 Oral market, 2018 - 2030 (USD Million)
Fig. 52 Injectable market, 2018 - 2030 (USD Million)
Fig. 53 Topical market, 2018 - 2030 (USD Million)
Fig. 54 Others market, 2018 - 2030 (USD Million)
Fig. 55 Veterinary Medicine market by Distribution Channel: Key takeaways
Fig. 56 Veterinary Medicine market by Distribution Channel, market share, 2023 & 2030
Fig. 57 Veterinary hospitals & clinics market, 2018 - 2030 (USD Million)
Fig. 58 E-commerce market, 2018 - 2030 (USD Million)
Fig. 59 Offline retail stores market, 2018 - 2030 (USD Million)
Fig. 60 Others market, 2018 - 2030 (USD Million)
Fig. 61 Veterinary Medicine market revenue, by region, 2023 & 2030, (USD Million)
Fig. 62 Regional Market Share Analysis, 2023 & 2030
Fig. 63 Regional Marketplace: Key Takeaways
Fig. 64 Regional Marketplace: Key Takeaways
Fig. 65 Regional Marketplace: Key Takeaways
Fig. 66 North America Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 U.S. Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Canada Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Europe Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Germany Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 UK Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 France Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Italy Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Spain Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Denmark Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Sweden Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Norway Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Netherlands Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Asia Pacific Veterinary Medicine market, 2018 - 2030 (USD Million)
Fig. 80 Japan Veterinary Medicine market, 2018 - 2030 (USD Million)
Fig. 81 China Veterinary Medicine market, 2018 - 2030 (USD Million)
Fig. 82 India Veterinary Medicine market, 2018 - 2030 (USD Million)
Fig. 83 Australia Veterinary Medicine market, 2018 - 2030 (USD Million)
Fig. 84 South Korea Veterinary Medicine market, 2018 - 2030 (USD Million)
Fig. 85 Thailand Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Latin America Veterinary Medicine market, 2018 - 2030 (USD Million)
Fig. 87 Brazil Veterinary Medicine market, 2018 - 2030 (USD Million)
Fig. 88 Mexico Veterinary Medicine market, 2018 - 2030 (USD Million)
Fig. 89 Argentina Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 MEA Veterinary Medicine market, 2018 - 2030 (USD Million)
Fig. 91 South Africa Veterinary Medicine market, 2018 - 2030 (USD Million)
Fig. 92 Saudi Arabia Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Egypt Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Kuwait Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 UAE Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Israel Veterinary Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Market participant categorization
Fig. 98 Heat map analysis
Fig. 99 Strategic Framework

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email